The London Joint Working Group on Substance Use and Hepatitis C
LJWG was formed in 2009 to help drive improvements in the prevention, diagnosis and treatment of hepatitis C in people who use drugs in London.
We work together to improve outcomes for people with hepatitis C in this vulnerable population. The LJWG collaborates with stakeholders from the health service, providers, policy makers, pharmaceutical companies and service users.
Hackney Harm Reduction Hub
In March 2024, we launched a new peer-based Hackney Harm Reduction Hub, working with our partners from Hackney Council and The Hepatitis C Trust and with people with living or lived experience of substance use. Read our report on the first year of operations here.
Book a hepatitis C test today
If you may be at risk of hepatitis C, you can now order a discreet, at-home testing kit for free on the NHS.
What we do
Projects
We run pilot projects to improve hepatitis C diagnosis, care and treatment across London.
Reports
We produce reports to help people understand the wider challenges
and overcome barriers to addressing hepatitis C.
Resources
We create well-researched and tested resources for substance use services and people at risk of hepatitis C.
Latest from the London Joint Working Group
Evaluation of the first year of operations of the Hackney Harm Reduction Hub (now SWERVE harm reduction hub)
December 15, 2025
This report is the culmination of the first year of the operation of a peer-led harm reduction hub in Hackney, delivered in partnership between the London Joint Working Group on Substance Use and Hepatitis C and The Hepatitis C Trust.
SWERVE Harm Reduction Hub opens permanent base
SWERVE (formerly Hackney Harm Reduction Hub), has moved into its permanent base in the Hackney CVS, E8 3AZ. Sterile works and harm reduction is available from this base Monday – Friday, 12-4pm.
Event: Understanding Safe Inhalation Pipe Provision (SIPP) and ways forward
December 13, 2024
On 12 December 2024, a hybrid meeting organised by a Haringey Public Health, Release, London School of Hygiene and Tropical Medicine (LSHTM) and the London Joint Working Group on Substance Use and Hepatitis C (LJWG), brought 70 public health experts, academics front line drugs workers and other interested individuals together to hear the latest research on the potential impact of safer inhalation pipe provision and the legal situation of this harm reduction approach.